Literature DB >> 19428497

The role of glutamate and its receptors in mesocorticolimbic dopaminergic regions in opioid addiction.

Yuan Guo1, Hui-Ling Wang, Xiao-Hui Xiang, Yan Zhao.   

Abstract

Accumulating evidence suggests that glutamate, as one of the most important excitatory neurotransmitters in the brain, plays a key role in drug addiction including opioid addiction. There is substantial evidence for glutamatergic projections into mesocorticolimbic dopaminergic neurons, which are associated with opioid psychological dependence and are also the key regions of enhancement effect. Glutamate may be involved in the process of opioid addiction not only by acting on its ionotropic and metabotropic glutamate receptors that activate several signal transduction pathways, but also by interacting with other neurotransmitters or neuropeptides such as opioids, dopamine, gamma-aminobutyric acid and substance P in the mesocorticolimbic dopaminergic regions. Studies on the role of glutamate and its receptors in opioid addiction will provide a new strategy for the exploitation of drugs for the treatment of opioid addiction.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19428497     DOI: 10.1016/j.neubiorev.2009.02.005

Source DB:  PubMed          Journal:  Neurosci Biobehav Rev        ISSN: 0149-7634            Impact factor:   8.989


  9 in total

1.  Metabotropic glutamate receptor blockade in nucleus accumbens shell shifts affective valence towards fear and disgust.

Authors:  Jocelyn M Richard; Kent C Berridge
Journal:  Eur J Neurosci       Date:  2010-12-29       Impact factor: 3.386

Review 2.  Current understanding on the pathogenesis of polyglutamine diseases.

Authors:  Xiao-Hui He; Fang Lin; Zheng-Hong Qin
Journal:  Neurosci Bull       Date:  2010-06       Impact factor: 5.203

Review 3.  Metabotropic and ionotropic glutamate receptors as potential targets for the treatment of alcohol use disorder.

Authors:  Sunil Goodwani; Hannah Saternos; Fawaz Alasmari; Youssef Sari
Journal:  Neurosci Biobehav Rev       Date:  2017-02-24       Impact factor: 8.989

4.  Ligands that interact with putative MOR-mGluR5 heteromer in mice with inflammatory pain produce potent antinociception.

Authors:  Eyup Akgün; Muhammad I Javed; Mary M Lunzer; Branden A Smeester; Al J Beitz; Philip S Portoghese
Journal:  Proc Natl Acad Sci U S A       Date:  2013-06-24       Impact factor: 11.205

Review 5.  Contribution of heteromerization to G protein-coupled receptor function.

Authors:  Supriya A Gaitonde; Javier González-Maeso
Journal:  Curr Opin Pharmacol       Date:  2016-11-09       Impact factor: 5.547

6.  Kinetic analysis of the metabotropic glutamate subtype 5 tracer [(18)F]FPEB in bolus and bolus-plus-constant-infusion studies in humans.

Authors:  Jenna M Sullivan; Keunpoong Lim; David Labaree; Shu-Fei Lin; Timothy J McCarthy; John P Seibyl; Gilles Tamagnan; Yiyun Huang; Richard E Carson; Yu-Shin Ding; Evan D Morris
Journal:  J Cereb Blood Flow Metab       Date:  2012-12-19       Impact factor: 6.200

7.  Changes in the levels of p-ERK, p-CREB, and c-fos in rat mesocorticolimbic dopaminergic system after morphine-induced conditioned place preference: the role of acute and subchronic stress.

Authors:  Abbas Haghparast; Zahra Fatahi; Shabnam Zeighamy Alamdary; Zahra Reisi; Fariba Khodagholi
Journal:  Cell Mol Neurobiol       Date:  2013-12-01       Impact factor: 5.046

8.  Blockade of Glutamate Receptors within the Prelimbic Cortex Attenuate Concentration of Excitatory Amino Acids in the Morphine Self-administration in Rats.

Authors:  Fateme Aboutalebi; Hojjatallah Alaei; Shahrbanoo Oryan
Journal:  Adv Biomed Res       Date:  2018-08-29

9.  Estimating Mental Health Conditions of Patients with Opioid Use Disorder.

Authors:  Christopher Minnerly; Steven L Bressler; Ibrahim M Shokry; Rui Tao
Journal:  J Addict       Date:  2019-09-26
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.